Martin Patricia A.
SEC insider (Form 3/4/5 filer). CIK 0001916764. Director at AN2 Therapeutics, Inc. (ANTX) and 1 other issuer. 23 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in MENLO PARK, CA.
Companies Martin Patricia A. has filed insider reports for
- AN2 Therapeutics, Inc. (ANTX): Director
- CYPHERPUNK TECHNOLOGIES INC. (CYPH): Director
Martin Patricia A.
CIK: 0001916764
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (23 total)
- Oct 12, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirect389 shares- - Sep 23, 2026CYPH
CYPHERPUNK TECHNOLOGIES INC.
SaleDirect50K shares at avg. $3.86$193K - Jul 10, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirect766 shares- - Jul 1, 2026CYPH
CYPHERPUNK TECHNOLOGIES INC.
AwardDirectRestricted Stock Units
75K shares- - Apr 10, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirect1.2K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirectStock Option (right to buy)
10.4K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirectStock Option (right to buy)
23.7K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
25K shares- - Mar 19, 2026ANTX
AN2 Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
10.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 |  ANTX AN2 Therapeutics, Inc. | Award | 389 | - | $0 | Direct |
| Sep 23, 2026 |  CYPH CYPHERPUNK TECHNOLOGIES INC. | Sale | 50,000 | $3.86 | $193,000 | Direct |
| Jul 10, 2026 | ANTX AN2 Therapeutics, Inc. | Award | 766 | - | $0 | Direct |
| Jul 1, 2026 | CYPH CYPHERPUNK TECHNOLOGIES INC. | Award Restricted Stock Units | 75,000 | - | - | Direct |
| Apr 10, 2026 | ANTX AN2 Therapeutics, Inc. | Award | 1,192 | - | $0 | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Award Stock Option (right to buy) | 10,362 | - | - | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Award Stock Option (right to buy) | 23,742 | - | - | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Award Stock Option (right to buy) | 24,999 | - | - | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Disposition Stock Option (right to buy) | 24,999 | - | - | Direct |
| Mar 19, 2026 | ANTX AN2 Therapeutics, Inc. | Disposition Stock Option (right to buy) | 10,362 | - | - | Direct |
1-10 of 23 transactions